Phase Ii Clinical Trial of Capecitabine in Ovarian Carcinoma Recurrent 6-12 Months After Completion of Primary Chemotherapy, with Exploratory Ts, Dpd, and Tp Correlates: A Gynecologic Oncology Group Study

AuthID
 P-00V-T4Q
7
Author(s)
Blessing J.A.
·
Lenz H.J.
·
Darcy K.M.
·
Mannel R.S.
·
Husseinzadeh N.
Document Type
Article
Year published
2005
Published
in Gynecologic Oncology, ISSN: 0090-8258
Volume: 96, Issue: 3, Pages: 810-817 (7)
Indexing
Scopus®
Crossref®11
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 15721430
Scopus: 2-s2.0-13844298089
Source Identifiers
ISSN: 0090-8258
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service